Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank75
5Y CAGR-52.2%
Studio
Year-over-Year Change

Year-over-year debt growth rate

5Y CAGR
-52.2%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20253.52%
2024323.50%
2023-1.58%
2022-46.38%
2021-44.35%
2020140.54%
2019480.65%
20182.48%
20170.00%
20160.00%